Fig. 2
From: The role of soluble CD80 in patients with soft tissue tumors
Receiver operating characteristic curve analysis. Diagnostic accuracy is evaluated by the area under the curve for identifying DOD (A AUC: 0.625, 95% CI 0.49–0.761), metastasis (B AUC: 0.641, 95% CI 0.514–0.767), and recurrence (C AUC: 0.50, 95% CI 0.362–0.639). A cutoff of 404 pg/mL results in sensitivity of 84.2% and specificity of 42.4% for identifying DOD, a cutoff of 531 sensitivity of 58.6% and specificity of 71.4% for identifying metastasis, and a cutoff of 284 sensitivity of 85.0% and specificity of 26.2% for identifying recurrence